Prophylactic zinc supplementation modulates hippocampal ionic zinc and partially remediates neurological recovery following repetitive mild head injury in mice

• Published in: Behavioural brain research Vol. 430; p. 113918
• Main Authors: Neely, C.L.C., Barkey, R.E., Hernandez, C.M., Flinn, J.M.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 26-07-2022
• Subjects: Chronic traumatic encephalopathy; Mouse model; Repetitive mild TBI; Sex differences; Traumatic brain injury; Zinc; MWM; Traumatic brain injury; Chronic traumatic encephalopathy; Zn; Repetitive mild TBI; CTE; Sex differences; EZM; Mouse model; TBI; OFT; Zinc
• ISSN: 0166-4328; 1872-7549
• DOI: 10.1016/j.bbr.2022.113918

Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative condition caused by repetitive mild traumatic brain injury (TBI) that leads to impaired executive functioning, emotional disturbances, and disordered memory, warranting both basic and translational research of potential therapeutic targets. One area of research concerns prophylactic zinc (Zn) supplementation; however, Zn supplementation remains poorly understood. This study explored the effects of Zn supplementation in a mouse model of repetitive mild TBI. Four-week-old male (n = 50) and female (n = 50) C57BL/6J mice consumed tap water or 10 parts per million Zn-supplemented water for eight weeks prior to injury. At 12 weeks of age, mice underwent either five sham procedures or five closed-head injuries spaced apart by 48 h after which they completed behavioral tests. Zinc-supplemented injured mice righted themselves and regained normal ambulatory function as fast as non-injured mice across four out of the five injury days. In contrast, non-supplemented injured mice exhibited impairment in normal ambulation by days 4 and 5. Injury also reduced free, ionic Zn in the dentate gyrus and CA3 region of the hippocampus and Zn supplementation partially remediated this reduction but not to the levels of non-injured mice. There were no structural differences in cortex, hippocampus, striatum, and corpus callosum, suggesting that Zn reduction was not due to macroscopic abnormalities. Overall, these results suggest that Zn may improve short-term and physical neurological recovery, but it may not be sufficient as a single pre-treatment for consequences of repetitive mild TBI such as cognitive impairment. These results further demonstrate the need for additional research documenting the underlying mechanisms of Zn in TBI-related neuropathology.